BamSEC and AlphaSense Join Forces
Learn More

Oramed Pharmaceuticals Inc. – Underwriting Agreements

NASDAQ: ORMP    
Share price (6/2/26): $3.60    
Market cap (6/2/26): $147 million
Search in Documents
Key Exhibits
External Links

Underwriting Agreements Filter

EX-1
from 8-A12B 43 pages Oramed Pharmaceuticals Inc. and Continental Stock Transfer & Trust Company, as Rights Agent Rights Agreement Dated as of November 17, 2025
12/34/56
EX-1.1
from 8-K 39 pages Oramed Pharmaceuticals Inc. Shares of Common Stock (Par Value $0.012 Per Share) at the Market Offering Agreement
12/34/56
EX-1.1
from 8-K 8 pages Strictly Confidential
12/34/56
EX-1.1
from 8-K 45 pages Oramed Pharmaceuticals Inc. Shares of Common Stock (Par Value $0.012 Per Share) Controlled Equity Offeringsm
12/34/56
EX-1.1
from 8-K 41 pages Oramed Pharmaceuticals Inc. $100,000,000 Equity Distribution Agreement
12/34/56
EX-1.1
from 8-K 43 pages Oramed Pharmaceuticals Inc. $28,000,000 Equity Distribution Agreement
12/34/56
EX-1.1
from 8-K 45 pages Oramed Pharmaceuticals Inc. $40,000,000 Equity Distribution Agreement
12/34/56
EX-1.1
from 8-K 34 pages 5,250,000 Shares Oramed Pharmaceuticals Inc. Common Stock Underwriting Agreement
12/34/56
EX-1.1
from 8-K 45 pages Oramed Pharmaceuticals Inc. $15,000,000 Equity Distribution Agreement
12/34/56
EX-1.1
from 8-K 9 pages Strictly Confidential
12/34/56
EX-1.1
from 8-K 8 pages Strictly Confidential
12/34/56
EX-1.1
from 8-K 40 pages Placement Agency Agreement Between Oramed Pharmaceuticals Inc. and Aegis Capital Corp., as Placement Agent Oramed Pharmaceuticals Inc. Placement Agency Agreement
12/34/56
EX-1.1
from 8-K 41 pages Placement Agency Agreement Between Oramed Pharmaceuticals Inc. and Aegis Capital Corp., as Representative of the Several Placement Agents Oramed Pharmaceuticals Inc. Placement Agency Agreement
12/34/56